Evaluation of the performance of a lateral flow device for quantitative detection of anti-SARS-CoV-2 IgG
Introduction: The AbC-19™ lateral flow immunoassay (LFIA) performance was evaluated on plasma samples from a SARS-CoV-2 vaccination cohort, WHO international standards for anti-SARS-CoV-2 IgG (human), individuals ≥2 weeks from infection of RT-PCR confirmed SARS-CoV-2 genetic variants, as well as mic...
Main Authors: | J.S. Moore, L.J. Robertson, R. Price, G. Curry, J. Farnan, A. Black, M.A. Nesbit, J.A. McLaughlin, T. Moore |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Clinical Immunology Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S277261342200021X |
Similar Items
-
Rapid detection of Staphylococcus aureus in blood culture samples using human IgG-based lateral flow assay
by: Arpasiri Srisrattakarn, et al.
Published: (2024-02-01) -
The Clinical Potential of Point-of-Care Quantitative Spectrochip Coupled with Lateral Flow Immunoassay during the COVID-19 Pandemic
by: Pang-Yen Chen, et al.
Published: (2021-01-01) -
High-Sensitive Detection and Quantitative Analysis of Thyroid-Stimulating Hormone Using Gold-Nanoshell-Based Lateral Flow Immunoassay Device
by: Santosh Kumar Bikkarolla, et al.
Published: (2022-03-01) -
One-Step Detection of Vancomycin in Whole Blood Using the Lateral Flow Immunoassay
by: Yugyung Jung, et al.
Published: (2024-02-01) -
Nucleic Acid Lateral Flow Immunoassay for the Detection of Pathogenic Bacteria from Food
by: M. Blažková, et al.
Published: (2009-06-01)